尼麦角林治疗慢性脑供血不足80例临床分析  

Clinical analysis of nicergoline in treatment for 80 patients with chronic cerebral circulation insufficiency

作　　者：肖静[1] 潘永霞[1] 唐明山[1] 

机构地区：[1]重庆市巴南区人民医院神经内科,重庆401320

出　　处：《局解手术学杂志》2014年第3期292-293,共2页Journal of Regional Anatomy and Operative Surgery

摘　　要：目的观察尼麦角林对治疗慢性脑供血不足的临床疗效。方法 160例慢性脑供血不足患者随机分为治疗组和对照组。治疗组在基础治疗的同时,给予尼麦角林10 mg,口服,3次/日;对照组给予尼莫地平20 mg,口服,3次/日,疗程1个月。观察临床有效率及经颅彩色多谱勒超声(TCD)检查的结果在治疗前后2组之间的变化。结果治疗组临床有效率及TCD指标改善情况均优于对照组,2组间差异具有统计学意义。结论尼麦角林治疗慢性脑供血不足安全可靠。Objective To observe the curative effect of nicergoline in the treatment of chronic cerebral circulation insufficiency （CC- CI）. Methods 160 cases with CCCI were randomly divided into the treatment group which were administered 10 mg of oral Nicergoline, three times per day for one month, and the control group which were given 20 mg of oral nimodipine, three times per day for one month. The clinical effective rate and the transcranial Doppler ultrasound （TCD） between the two groups before and after treatment were observed. Results There were significant difference in clinical effective rate and TCD index assessment between the two groups （ P 〈 0. 05 ）. Conclu- sion Nieergoline is an effective and safe treatment for chronic cerebral circulation insufficiency.

关 键 词：慢性脑供血不足 尼麦角林 临床疗效 

分 类 号：R743[医药卫生—神经病学与精神病学]